Included In This Lesson
What is the Generic Name
What is the Trade Name for BROLUCIZUMAB
What is the Indication for BROLUCIZUMAB
- 1 INDICATIONS AND USAGE BEOVU ¬Æ is indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD). BEOVU is a human vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of Neovascular (Wet) Age-Related Macular Degeneration (AMD) ( 1 ).
View Our Nursing Pharmacology Course
Other Pharm Resources